News & updates

The latest updates from Vetosine

17128584 vetosine logo final

STONEHAVEN INCUBATE LAUNCHES NEW COMPANY AIMING TO TACKLE CANINE OSTEOARTHRITIS

Published Wednesday, 5th May 2021
Stonehaven Incubate has partnered with human health player Regenosine to launch Vetosine, a new company that will develop and commercialize a first-in-class disease modifying osteoarthritis drug (DMOAD) for animals, with an initial focus on dogs.
Read more
Page 1 of 1

Cookie policy

We use necessary cookies to allow our site to function correctly. You can disable these via your browser settings but this site may not function correctly if you do so. We also use optional cookies to collect anonymised visitor statistics to help us identify issues and improve our web site. View our privacy policy here

Cookies